Are there risks or serious side effects I should know about before starting tirzepatide
Health Canada approves 1st generic version of Ozempic Health Canada has approved the first generic version of brand-name Ozempic
Prevention of muscle loss with dietary approach Given the sarcopenia-related increase in morbidity and mortality, preventing muscle mass loss in patients taking weight-loss drugs, such as GLP-1RAs, is of primary importance and should include both physical exercise and dietary strategies [37]
When you begin a journey toward better metabolic health, you pay close attention to every change in your body
UCDavis Health (2023) Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10), Diabetes & Metabolism (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials, The Lancet (2019) Management of Hyperglycemia in Type 2 Diabetes, 2018
The FDA has not approved any microneedle patch containing GLP-1 or Semaglutide for over-the-counter weight loss
